Neuronetics (NASDAQ:STIM) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.14) by 50 percent. This is a 22.22 percent increase over losses of $(0.27) per share from the same period last year. The company reported quarterly sales of $31.98 million which beat the analyst consensus estimate of $29.07 million by 10.00 percent. This is a 83.59 percent increase over sales of $17.42 million the same period last year.